Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical

Provided By PR Newswire

Last update: Jul 31, 2025

ALPHARETTA, Ga., July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.